Cell therapies treat and repair the body using stem cells or their derivatives. These cells possess great therapeutic potential, but their beneficial effects often fade away over time. In this episode, we explore strategies to improve the persistence of stem cell-derived cardiomyocytes in the effort to remuscularize hearts after cardiac infarction. 

Niki Spahich from The Scientist’s Creative Services team spoke with Sara Nunes Vasconcelos, an assistant professor at the Institute of Biomaterials & Biomedical Engineering, University of Toronto, and a scientist at the Toronto General Hospital Research Institute, to learn more.

Interested in reading more?

Improving Cardiac Cell Therapy Persistence

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?